AzTrials
AzTrials

Rotator Cuff InjuryS-TRONGERNCT06788327

Blood Flow Restriction Versus Standard Exercise After Rotator Cuff Repair

A study testing Standard rehabilitation and Blood Flow Restriction Therapy in people with Rotator Cuff Injury and Rotator Cuff Tears, run by University of Valencia at 1 site in Chile.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to determine the effectiveness of postoperative standard exercises with blood flow restriction therapy (BFRT) versus standard exercises alone on shoulder muscle strength and mass in participants with surgically treated rotator cuff tear. Read more about this study

Who is it for?
Ages 40 to 65 years
What is being tested?
Standard rehabilitation and Blood Flow Restriction Therapy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteChile
Study dates
3 Mar 2025to 31 Aug 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age between 40-65 years
  • Symptomatic degenerative rotator cuff tear diagnosed by magnetic resonance imaging
  • Undergoing arthroscopic rotator cuff repair
  • Be able to read and understand Spanish

Who cannot join

  • Massive irreparable rotator cuff tear
  • Concomitant fracture
  • Labral or nerve injury
  • Suspicious of developing a frozen shoulder
  • Revision surgery after rotator cuff repair
  • Previous corticosteroid injection (< 6 months)
Show all 9Show fewer
  • Recent surgery (< 1 year) in the contralateral shoulder
  • History of deep venous thrombosis/pulmonary embolism, peripheral vascular disease, thrombophilia or clotting disorders
  • Severe or uncontrolled hypertension, or any comorbid condition that impedes participants to complete the intervention

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

José Casaña, PhD contact

+34656437371

jose.casana@uv.es

Felipe Ponce-Fuentes, MSc contact

+56954411974

felipe.poncef@umayor.cl

Chile1 site
  • Clínica RedSalud Mayor

    Temuco, Cautín, 4800580

    Daniela Mansilla, +56996521664, daniela.mansilla@redsalud.cl

    Felipe Ponce-Fuentes, MSc

Other trials in Chile

About this study

Official title: Comparing the Effectiveness of Blood Flow Restriction Therapy Versus Standard Exercise After Arthroscopic Rotator Cuff Repair: Protocol for the Multicenter S-TRONGER Randomized Controlled Trial

The goal of this clinical trial is to determine the effectiveness of postoperative standard exercises with blood flow restriction therapy (BFRT) versus standard exercises alone on shoulder muscle strength and mass in participants with surgically treated rotator cuff tear. It is presumed that the addition of BFRT will significantly improve the shoulder strength and muscle mass at the end of the intervention period compared to the group receiving only standard exercises.

Patients who agree to participate in this research will be randomly assigned to a control group (standard exercises alone) or an experimental group (standard rehabilitation with BFRT). The duration of the postoperative intervention will be 12 weeks. The primary variables will be the shoulder muscle strength and muscle mass. Secondary variables will be the active shoulder mobility, pain intensity, upper limb disability, and health-related quality of life. Results will be measured at 0, 4 and 12 weeks postoperative.

Being tested
Standard rehabilitation, Blood Flow Restriction Therapy
Keywords
blood flow restriction therapy, blood flow restriction training
Medical subject headings
Rotator Cuff Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Standard rehabilitationOther

    Protocol based on the best available evidence and to be used in all participants in both groups. The standard exercises protocol will consist of three postoperative rehabilitation phases: phase I (weeks 1 to 4), phase II (weeks 5 to 8) and phase III (weeks 9 to 12). Sessions will be held 2 times a week for 12 weeks. Each session will last 45 minutes and will consist of six exercises in the phase I, eight exercises in phase II, and eight exercises in phase III.

  • Blood Flow Restriction TherapyDevice

    Participants will perform three exercises of the standard exercises protocol with BFRT. An auto-regulated portable BFRT SmartCuffs® 3.0 Pro system with a 17-inch long and 5-inch-wide cuff (Smart Tools Plus, United States), placed on the most proximal part of the arm, will be used. Each BFRT session will begin with a maximal occlusion test to personalize the occlusion pressure to the participant. The limb occlusion pressure (LOP) will be set at 50% of the maximum occlusion pressure in the first stage and 60% in stages II and III. The participant will perform 75 repetitions per BFRT exercise divided into 4 sets (30, 15, 15, and 15 repetitions). The load intensity during the BFRT exercises will be set near to 3 out of 10 on the Borg's CR10 scale ("weak"), which corresponds to 30% of a 1RM effort. After each exercise, the cuff will be deflated, and the patient will rest for two minutes.

Study groups in NCT06788327
Study groupRoleWhat they receive
Standard exercises with BFRTExperimentalParticipants with arthroscopic rotator cuff repair will undergo rehabilitation using progressive exercises with BFRT during the three phases of standard rehabilitation.
Receives: Other: Standard rehabilitation; Device: Blood Flow Restriction Therapy
Standard exercises aloneActive comparatorParticipants with arthroscopic rotator cuff repair will undergo rehabilitation using progressive exercises without BFRT during the three phases of standard rehabilitation.
Receives: Other: Standard rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Shoulder muscle strength

    Shoulder abduction and external rotation maximum voluntary isometric strength will be measured using dynamometry (kilograms)

    Measured: 0, 4 and 12 weeks

  2. Shoulder muscle mass

    Supraspinatus and long head biceps brachii tendon thickness will be measured using ultrasound imaging (milimeters)

    Measured: 0, 4 and 12 weeks

Secondary outcomes (4)
  1. Active Range of Motion

    Shoulder flexion, abduction, and external rotation will be measured with a goniometer (degrees)

    Measured: 0, 4 and 12 weeks

  2. Pain intensity

    Visual Analogue Scale (0 to 10 centimeters)

    Measured: 0, 4 and 12 weeks

  3. Self-reported upper limb disability

    Shoulder Pain Disability Index (0 to 100%)

    Measured: 0, 4 and 12 weeks

  4. Self-reported quality of life

    Western Ontario Rotator Cuff Index (0 to 100%)

    Measured: 0, 4 and 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2025
  2. Study start3 Mar 2025 (estimated)
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06788327
Sponsor's protocol ID
BFRT in RCR rehabilitation
Acronym
S-TRONGER
Status last verified
Jan 2025
First submitted
15 Jan 2025
Last updated
23 Jan 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Patterson SD, Hughes L, Warmington S, Burr J, Scott BR, Owens J, Abe T, Nielsen JL, Libardi CA, Laurentino G, Neto GR, Brandner C, Martin-Hernandez J, Loenneke J. Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety. Front Physiol. 2019 May 15;10:533. doi: 10.3389/fphys.2019.00533. eCollection 2019.

    PubMed 31156448
  • Lambert BS, Hedt C, Ankersen JP, Goble H, Taft C, Daum J, Karasch R, Moreno MR, McCulloch PC. Rotator cuff training with upper extremity blood flow restriction produces favorable adaptations in division IA collegiate pitchers: a randomized trial. J Shoulder Elbow Surg. 2023 Jun;32(6):e279-e292. doi: 10.1016/j.jse.2023.02.116. Epub 2023 Mar 17.

    PubMed 36933646
  • Lambert B, Hedt C, Daum J, Taft C, Chaliki K, Epner E, McCulloch P. Blood Flow Restriction Training for the Shoulder: A Case for Proximal Benefit. Am J Sports Med. 2021 Aug;49(10):2716-2728. doi: 10.1177/03635465211017524. Epub 2021 Jun 10.

    PubMed 34110960
  • Kjaer BH, Magnusson SP, Henriksen M, Warming S, Boyle E, Krogsgaard MR, Al-Hamdani A, Juul-Kristensen B. Effects of 12 Weeks of Progressive Early Active Exercise Therapy After Surgical Rotator Cuff Repair: 12 Weeks and 1-Year Results From the CUT-N-MOVE Randomized Controlled Trial. Am J Sports Med. 2021 Feb;49(2):321-331. doi: 10.1177/0363546520983823. Epub 2021 Jan 20.

    PubMed 33471547
  • Kara D, Ozcakar L, Demirci S, Huri G, Duzgun I. Blood Flow Restriction Training in Patients With Rotator Cuff Tendinopathy: A Randomized, Assessor-Blinded, Controlled Trial. Clin J Sport Med. 2024 Jan 1;34(1):10-16. doi: 10.1097/JSM.0000000000001191. Epub 2023 Sep 14.

    PubMed 37706671
  • Hughes L, Patterson SD. The effect of blood flow restriction exercise on exercise-induced hypoalgesia and endogenous opioid and endocannabinoid mechanisms of pain modulation. J Appl Physiol (1985). 2020 Apr 1;128(4):914-924. doi: 10.1152/japplphysiol.00768.2019. Epub 2020 Feb 27.

    PubMed 32105522
  • Bowman EN, Elshaar R, Milligan H, Jue G, Mohr K, Brown P, Watanabe DM, Limpisvasti O. Upper-extremity blood flow restriction: the proximal, distal, and contralateral effects-a randomized controlled trial. J Shoulder Elbow Surg. 2020 Jun;29(6):1267-1274. doi: 10.1016/j.jse.2020.02.003.

    PubMed 32423577

Questions about this trial

What is this clinical trial studying?

A study testing Standard rehabilitation and Blood Flow Restriction Therapy in people with Rotator Cuff Injury and Rotator Cuff Tears, run by University of Valencia at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 23 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact José Casaña, PhD (+34656437371, jose.casana@uv.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Shoulder muscle strength (time frame: 0, 4 and 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06788327, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in